mbeck

Soil stops bleeding: NMIN researcher

NMIN research co-leader Dr. Christan Kastrup and his research team find that soil silicates play a key role in blood clotting Research led by Dr. Christian Kastrup and published in Blood Advances has found that soil silicates in wounds help activate a blood known as protein coagulation Factor XII. This… Read More »Soil stops bleeding: NMIN researcher

Inaugural NMIN Postdoctoral Award winners announced

The NanoMedicines Innovation Network (NMIN) is pleased to announce the recipients of its inaugural NMIN Postdoctoral Awards: Dr. Noorjahan Aibani and Dr. Jayesh Kulkarni. Details about both recipients and their research plans follow below. The awardees were selected by the members of NMIN’s Research Management Committee, based on the applicants’… Read More »Inaugural NMIN Postdoctoral Award winners announced

The Ins & Outs of Gene Therapy Drug Development: an interview with NMIN’s Scientific Director

In an insightful 42-minute interview, NMIN’s Scientific Director Dr. Pieter Cullis, a pioneer in liposomal gene and drug delivery, discusses his scientific career with a focus on his contributions to the evolution of gene therapy. https://www.youtube.com/watch?v=ERU-3b6YtUkThe interview was conducted on behalf of the Gene Delivery and Gene Editing focus group… Read More »The Ins & Outs of Gene Therapy Drug Development: an interview with NMIN’s Scientific Director

NMIN research leader’s finding selected as journal’s feature article

Research by NMIN research leader Dr. Marcel Bally and team at Cuprous Pharmaceuticals is featured on the cover of the February 2020 issue of Drug Delivery and Translational Research. The article, Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use, discusses the benefits brought to quercetin by Cuprous’ Metaplex… Read More »NMIN research leader’s finding selected as journal’s feature article

“A new era of medicine:” NMIN thought leaders in Nature Nanotechnology

On August 10, 2018 the US Food and Drug Administration (FDA) approved ONPATTRO™, a nanomedicine for treating the devastating and usually lethal hereditary illness known as hereditary transthyretin-induced amyloidosis (hATTR). The approval of ONPATTRO™ has opened the door to a new era of gene therapies to treat most human diseases—including… Read More »“A new era of medicine:” NMIN thought leaders in Nature Nanotechnology

NMIN holds its first Scientific Meeting

Over 100 delegates—researchers, trainees, partner organization representatives and other stakeholders—gathered at the Sheraton Vancouver Wall Centre in Vancouver, British Columbia, on September 13-14, 2019, to take part in NMIN’s first Scientific Meeting. Previous Next Read about the event in NMIN’s November 2019 Newsletter. See the Event Program for the full agenda, speakers’… Read More »NMIN holds its first Scientific Meeting